nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—Leflunomide—rheumatoid arthritis	0.0786	0.156	CbGbCtD
Sitaxentan—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0505	0.1	CbGbCtD
Sitaxentan—CYP2C19—Prednisone—rheumatoid arthritis	0.0467	0.0925	CbGbCtD
Sitaxentan—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0443	0.0877	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0372	0.0738	CbGbCtD
Sitaxentan—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0368	0.0729	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—rheumatoid arthritis	0.0291	0.0578	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0282	0.056	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0242	0.048	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—rheumatoid arthritis	0.0242	0.048	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—rheumatoid arthritis	0.0239	0.0474	CbGbCtD
Sitaxentan—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0227	0.0449	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—rheumatoid arthritis	0.0226	0.0447	CbGbCtD
Sitaxentan—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0214	0.0424	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0141	0.0279	CbGbCtD
Sitaxentan—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000145	0.000403	CcSEcCtD
Sitaxentan—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000145	0.000402	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000144	0.000402	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—rheumatoid arthritis	0.000144	0.000402	CcSEcCtD
Sitaxentan—Rash—Azathioprine—rheumatoid arthritis	0.000144	0.000401	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000144	0.000401	CcSEcCtD
Sitaxentan—Dermatitis—Azathioprine—rheumatoid arthritis	0.000144	0.000401	CcSEcCtD
Sitaxentan—Flushing—Prednisone—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Ill-defined disorder—Betamethasone—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Discomfort—Triamcinolone—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Fatigue—Cyclosporine—rheumatoid arthritis	0.000144	0.0004	CcSEcCtD
Sitaxentan—Discomfort—Methylprednisolone—rheumatoid arthritis	0.000143	0.000399	CcSEcCtD
Sitaxentan—Headache—Azathioprine—rheumatoid arthritis	0.000143	0.000398	CcSEcCtD
Sitaxentan—Dizziness—Leflunomide—rheumatoid arthritis	0.000143	0.000397	CcSEcCtD
Sitaxentan—Pain—Cyclosporine—rheumatoid arthritis	0.000143	0.000396	CcSEcCtD
Sitaxentan—Constipation—Cyclosporine—rheumatoid arthritis	0.000143	0.000396	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000142	0.000396	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—rheumatoid arthritis	0.000142	0.000395	CcSEcCtD
Sitaxentan—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000141	0.000393	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—rheumatoid arthritis	0.000141	0.000392	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—rheumatoid arthritis	0.000141	0.000391	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—rheumatoid arthritis	0.00014	0.00039	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—rheumatoid arthritis	0.00014	0.00039	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—rheumatoid arthritis	0.00014	0.00039	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—rheumatoid arthritis	0.00014	0.000389	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—rheumatoid arthritis	0.00014	0.000389	CcSEcCtD
Sitaxentan—Oedema—Triamcinolone—rheumatoid arthritis	0.00014	0.000388	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—rheumatoid arthritis	0.000139	0.000388	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—rheumatoid arthritis	0.000139	0.000388	CcSEcCtD
Sitaxentan—Infection—Triamcinolone—rheumatoid arthritis	0.000139	0.000385	CcSEcCtD
Sitaxentan—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000138	0.000385	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—rheumatoid arthritis	0.000138	0.000385	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—rheumatoid arthritis	0.000138	0.000383	CcSEcCtD
Sitaxentan—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000137	0.000382	CcSEcCtD
Sitaxentan—Vomiting—Leflunomide—rheumatoid arthritis	0.000137	0.000382	CcSEcCtD
Sitaxentan—Insomnia—Prednisolone—rheumatoid arthritis	0.000137	0.000382	CcSEcCtD
Sitaxentan—Alopecia—Prednisone—rheumatoid arthritis	0.000137	0.000381	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000137	0.00038	CcSEcCtD
Sitaxentan—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000137	0.00038	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—rheumatoid arthritis	0.000136	0.000379	CcSEcCtD
Sitaxentan—Rash—Leflunomide—rheumatoid arthritis	0.000136	0.000379	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000136	0.000379	CcSEcCtD
Sitaxentan—Dermatitis—Leflunomide—rheumatoid arthritis	0.000136	0.000378	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—rheumatoid arthritis	0.000136	0.000378	CcSEcCtD
Sitaxentan—Nausea—Azathioprine—rheumatoid arthritis	0.000136	0.000378	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000136	0.000378	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000135	0.000997	CbGpPWpGaD
Sitaxentan—Headache—Leflunomide—rheumatoid arthritis	0.000135	0.000376	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000135	0.000995	CbGpPWpGaD
Sitaxentan—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000135	0.000376	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—rheumatoid arthritis	0.000135	0.000376	CcSEcCtD
Sitaxentan—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000134	0.000373	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000133	0.000982	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000133	0.000979	CbGpPWpGaD
Sitaxentan—Urticaria—Cyclosporine—rheumatoid arthritis	0.000132	0.000368	CcSEcCtD
Sitaxentan—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000132	0.000366	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—C5—rheumatoid arthritis	0.000131	0.000961	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000131	0.000961	CbGpPWpGaD
Sitaxentan—Discomfort—Dexamethasone—rheumatoid arthritis	0.00013	0.000363	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—rheumatoid arthritis	0.00013	0.000363	CcSEcCtD
Sitaxentan—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.00013	0.000363	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—MMP3—rheumatoid arthritis	0.00013	0.000959	CbGpPWpGaD
Sitaxentan—Haemoglobin—Methotrexate—rheumatoid arthritis	0.00013	0.000362	CcSEcCtD
Sitaxentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.00013	0.000957	CbGpPWpGaD
Sitaxentan—Hypotension—Methylprednisolone—rheumatoid arthritis	0.00013	0.000362	CcSEcCtD
Sitaxentan—Pain—Prednisolone—rheumatoid arthritis	0.00013	0.000361	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—rheumatoid arthritis	0.00013	0.000361	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—rheumatoid arthritis	0.00013	0.000361	CcSEcCtD
Sitaxentan—CYP2C19—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.00013	0.000953	CbGpPWpGaD
Sitaxentan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000129	0.000358	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000129	0.000946	CbGpPWpGaD
Sitaxentan—Nausea—Leflunomide—rheumatoid arthritis	0.000128	0.000357	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000128	0.000356	CcSEcCtD
Sitaxentan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000128	0.000941	CbGpPWpGaD
Sitaxentan—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000128	0.000356	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000128	0.00094	CbGpPWpGaD
Sitaxentan—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000128	0.000355	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000127	0.000938	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000127	0.000938	CbGpPWpGaD
Sitaxentan—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000127	0.000353	CcSEcCtD
Sitaxentan—Pain—Hydrocortisone—rheumatoid arthritis	0.000127	0.000352	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—rheumatoid arthritis	0.000127	0.000352	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—rheumatoid arthritis	0.000127	0.000352	CcSEcCtD
Sitaxentan—Insomnia—Triamcinolone—rheumatoid arthritis	0.000126	0.000351	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000126	0.000927	CbGpPWpGaD
Sitaxentan—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000126	0.00035	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—rheumatoid arthritis	0.000126	0.00035	CcSEcCtD
Sitaxentan—Infection—Betamethasone—rheumatoid arthritis	0.000126	0.00035	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000125	0.000349	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000125	0.000348	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—rheumatoid arthritis	0.000125	0.000348	CcSEcCtD
Sitaxentan—Anaemia—Prednisone—rheumatoid arthritis	0.000125	0.000347	CcSEcCtD
Sitaxentan—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000124	0.000345	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000124	0.000345	CcSEcCtD
Sitaxentan—Agitation—Prednisone—rheumatoid arthritis	0.000124	0.000345	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000124	0.000345	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000124	0.000345	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—rheumatoid arthritis	0.000124	0.000344	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000124	0.000344	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000123	0.000905	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR6—rheumatoid arthritis	0.000123	0.000904	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000123	0.000342	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000123	0.000341	CcSEcCtD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000123	0.000903	CbGpPWpGaD
Sitaxentan—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000123	0.000341	CcSEcCtD
Sitaxentan—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000122	0.00034	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000122	0.000898	CbGpPWpGaD
Sitaxentan—Malaise—Prednisone—rheumatoid arthritis	0.000122	0.000339	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—rheumatoid arthritis	0.000121	0.000337	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000121	0.000892	CbGpPWpGaD
Sitaxentan—Eye disorder—Methotrexate—rheumatoid arthritis	0.000121	0.000337	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—rheumatoid arthritis	0.000121	0.000336	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—POMC—rheumatoid arthritis	0.000121	0.000889	CbGpPWpGaD
Sitaxentan—Anorexia—Dexamethasone—rheumatoid arthritis	0.000121	0.000336	CcSEcCtD
Sitaxentan—Anorexia—Betamethasone—rheumatoid arthritis	0.000121	0.000336	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—rheumatoid arthritis	0.000121	0.000335	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.00012	0.000335	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.00012	0.000885	CbGpPWpGaD
Sitaxentan—Fatigue—Triamcinolone—rheumatoid arthritis	0.00012	0.000334	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—rheumatoid arthritis	0.00012	0.000334	CcSEcCtD
Sitaxentan—Asthenia—Cyclosporine—rheumatoid arthritis	0.00012	0.000333	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NCF2—rheumatoid arthritis	0.00012	0.000879	CbGpPWpGaD
Sitaxentan—Pain—Triamcinolone—rheumatoid arthritis	0.000119	0.000332	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—C3—rheumatoid arthritis	0.000119	0.000877	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000119	0.000874	CbGpPWpGaD
Sitaxentan—Hypotension—Betamethasone—rheumatoid arthritis	0.000118	0.000329	CcSEcCtD
Sitaxentan—Hypotension—Dexamethasone—rheumatoid arthritis	0.000118	0.000329	CcSEcCtD
Sitaxentan—EDNRA—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000118	0.00087	CbGpPWpGaD
Sitaxentan—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.000118	0.000869	CbGpPWpGaD
Sitaxentan—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000118	0.000327	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—rheumatoid arthritis	0.000118	0.000327	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000117	0.000326	CcSEcCtD
Sitaxentan—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000117	0.000326	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000117	0.000325	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000116	0.000857	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000116	0.000857	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000116	0.000856	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000116	0.000851	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000116	0.000851	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GZMB—rheumatoid arthritis	0.000116	0.000851	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000115	0.00032	CcSEcCtD
Sitaxentan—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000115	0.000319	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—rheumatoid arthritis	0.000115	0.000319	CcSEcCtD
Sitaxentan—Insomnia—Dexamethasone—rheumatoid arthritis	0.000114	0.000318	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—rheumatoid arthritis	0.000114	0.000318	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000114	0.000842	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000114	0.000318	CcSEcCtD
Sitaxentan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000114	0.000317	CcSEcCtD
Sitaxentan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000114	0.000837	CbGpPWpGaD
Sitaxentan—Discomfort—Prednisone—rheumatoid arthritis	0.000114	0.000316	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—rheumatoid arthritis	0.000114	0.000316	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—rheumatoid arthritis	0.000113	0.000314	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000113	0.00083	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000113	0.000829	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000112	0.000827	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL3—rheumatoid arthritis	0.000112	0.000827	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000112	0.000311	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000111	0.00031	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000111	0.00031	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000111	0.000815	CbGpPWpGaD
Sitaxentan—Urticaria—Triamcinolone—rheumatoid arthritis	0.000111	0.000308	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000111	0.000308	CcSEcCtD
Sitaxentan—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00011	0.000307	CcSEcCtD
Sitaxentan—Dizziness—Cyclosporine—rheumatoid arthritis	0.00011	0.000307	CcSEcCtD
Sitaxentan—Oedema—Prednisone—rheumatoid arthritis	0.00011	0.000307	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.00011	0.000306	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.00011	0.000306	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—SAA1—rheumatoid arthritis	0.00011	0.000808	CbGpPWpGaD
Sitaxentan—Infection—Prednisone—rheumatoid arthritis	0.00011	0.000305	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000109	0.000304	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000109	0.000304	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000109	0.000804	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000109	0.000304	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—rheumatoid arthritis	0.000109	0.000303	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—rheumatoid arthritis	0.000109	0.000303	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—C3—rheumatoid arthritis	0.000108	0.000797	CbGpPWpGaD
Sitaxentan—Pain—Dexamethasone—rheumatoid arthritis	0.000108	0.000301	CcSEcCtD
Sitaxentan—Pain—Betamethasone—rheumatoid arthritis	0.000108	0.000301	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000108	0.000301	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000108	0.000794	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NCF1—rheumatoid arthritis	0.000108	0.000792	CbGpPWpGaD
Sitaxentan—Tachycardia—Prednisone—rheumatoid arthritis	0.000108	0.000299	CcSEcCtD
Sitaxentan—Skin disorder—Prednisone—rheumatoid arthritis	0.000107	0.000298	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000107	0.000786	CbGpPWpGaD
Sitaxentan—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000106	0.000296	CcSEcCtD
Sitaxentan—Vomiting—Cyclosporine—rheumatoid arthritis	0.000106	0.000295	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000106	0.000777	CbGpPWpGaD
Sitaxentan—Rash—Cyclosporine—rheumatoid arthritis	0.000105	0.000292	CcSEcCtD
Sitaxentan—Anorexia—Prednisone—rheumatoid arthritis	0.000105	0.000292	CcSEcCtD
Sitaxentan—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000105	0.000292	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000105	0.000291	CcSEcCtD
Sitaxentan—Headache—Cyclosporine—rheumatoid arthritis	0.000104	0.00029	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—rheumatoid arthritis	0.000104	0.00029	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000104	0.00029	CcSEcCtD
Sitaxentan—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000104	0.00029	CcSEcCtD
Sitaxentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000104	0.000763	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD28—rheumatoid arthritis	0.000103	0.000761	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000103	0.000286	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000103	0.000285	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000102	0.000753	CbGpPWpGaD
Sitaxentan—Malaise—Methotrexate—rheumatoid arthritis	0.000102	0.000283	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000102	0.000748	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TLE3—rheumatoid arthritis	0.000102	0.000748	CbGpPWpGaD
Sitaxentan—Vertigo—Methotrexate—rheumatoid arthritis	0.000101	0.000282	CcSEcCtD
Sitaxentan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000101	0.000282	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—rheumatoid arthritis	0.000101	0.000281	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000101	0.00074	CbGpPWpGaD
Sitaxentan—Urticaria—Dexamethasone—rheumatoid arthritis	0.000101	0.00028	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—rheumatoid arthritis	0.000101	0.00028	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—rheumatoid arthritis	0.0001	0.000279	CcSEcCtD
Sitaxentan—Asthenia—Triamcinolone—rheumatoid arthritis	0.0001	0.000278	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—rheumatoid arthritis	0.0001	0.000278	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.0001	0.000278	CcSEcCtD
Sitaxentan—Asthenia—Methylprednisolone—rheumatoid arthritis	9.99e-05	0.000278	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—rheumatoid arthritis	9.97e-05	0.000277	CcSEcCtD
Sitaxentan—Nausea—Cyclosporine—rheumatoid arthritis	9.9e-05	0.000275	CcSEcCtD
Sitaxentan—Dizziness—Hydrocortisone—rheumatoid arthritis	9.8e-05	0.000272	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—UBE2D1—rheumatoid arthritis	9.74e-05	0.000717	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	9.74e-05	0.000717	CbGpPWpGaD
Sitaxentan—Dyspepsia—Prednisone—rheumatoid arthritis	9.7e-05	0.00027	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL5—rheumatoid arthritis	9.7e-05	0.000713	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RB—rheumatoid arthritis	9.68e-05	0.000712	CbGpPWpGaD
Sitaxentan—Chest pain—Methotrexate—rheumatoid arthritis	9.61e-05	0.000267	CcSEcCtD
Sitaxentan—Decreased appetite—Prednisone—rheumatoid arthritis	9.58e-05	0.000266	CcSEcCtD
Sitaxentan—Rash—Prednisolone—rheumatoid arthritis	9.56e-05	0.000266	CcSEcCtD
Sitaxentan—Dermatitis—Prednisolone—rheumatoid arthritis	9.56e-05	0.000266	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—BDKRB2—rheumatoid arthritis	9.55e-05	0.000703	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL12—rheumatoid arthritis	9.55e-05	0.000703	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CSF2—rheumatoid arthritis	9.55e-05	0.000703	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.54e-05	0.000265	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—POMC—rheumatoid arthritis	9.54e-05	0.000702	CbGpPWpGaD
Sitaxentan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.52e-05	0.000265	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—rheumatoid arthritis	9.5e-05	0.000264	CcSEcCtD
Sitaxentan—Headache—Prednisolone—rheumatoid arthritis	9.5e-05	0.000264	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—rheumatoid arthritis	9.49e-05	0.000264	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL6ST—rheumatoid arthritis	9.47e-05	0.000697	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADRBK1—rheumatoid arthritis	9.45e-05	0.000695	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	9.44e-05	0.000694	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	9.44e-05	0.000694	CbGpPWpGaD
Sitaxentan—Constipation—Prednisone—rheumatoid arthritis	9.43e-05	0.000262	CcSEcCtD
Sitaxentan—Vomiting—Hydrocortisone—rheumatoid arthritis	9.42e-05	0.000262	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—C5—rheumatoid arthritis	9.35e-05	0.000688	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL8—rheumatoid arthritis	9.35e-05	0.000688	CbGpPWpGaD
Sitaxentan—Rash—Hydrocortisone—rheumatoid arthritis	9.34e-05	0.00026	CcSEcCtD
Sitaxentan—Dermatitis—Hydrocortisone—rheumatoid arthritis	9.33e-05	0.00026	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—MMP3—rheumatoid arthritis	9.33e-05	0.000686	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	9.31e-05	0.000685	CbGpPWpGaD
Sitaxentan—Confusional state—Methotrexate—rheumatoid arthritis	9.29e-05	0.000258	CcSEcCtD
Sitaxentan—Headache—Hydrocortisone—rheumatoid arthritis	9.28e-05	0.000258	CcSEcCtD
Sitaxentan—Dizziness—Triamcinolone—rheumatoid arthritis	9.22e-05	0.000257	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—rheumatoid arthritis	9.2e-05	0.000256	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NFATC1—rheumatoid arthritis	9.2e-05	0.000677	CbGpPWpGaD
Sitaxentan—Infection—Methotrexate—rheumatoid arthritis	9.15e-05	0.000255	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisone—rheumatoid arthritis	9.08e-05	0.000253	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—rheumatoid arthritis	9.08e-05	0.000253	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—rheumatoid arthritis	9.08e-05	0.000253	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—rheumatoid arthritis	9.03e-05	0.000251	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—rheumatoid arthritis	9.02e-05	0.000251	CcSEcCtD
Sitaxentan—Nausea—Prednisolone—rheumatoid arthritis	9.01e-05	0.000251	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—rheumatoid arthritis	8.95e-05	0.000249	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.91e-05	0.000655	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SYK—rheumatoid arthritis	8.88e-05	0.000653	CbGpPWpGaD
Sitaxentan—Vomiting—Triamcinolone—rheumatoid arthritis	8.87e-05	0.000247	CcSEcCtD
Sitaxentan—Vomiting—Methylprednisolone—rheumatoid arthritis	8.85e-05	0.000246	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCL5—rheumatoid arthritis	8.81e-05	0.000648	CbGpPWpGaD
Sitaxentan—Nausea—Hydrocortisone—rheumatoid arthritis	8.8e-05	0.000245	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—rheumatoid arthritis	8.8e-05	0.000245	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CCR6—rheumatoid arthritis	8.79e-05	0.000647	CbGpPWpGaD
Sitaxentan—Dermatitis—Triamcinolone—rheumatoid arthritis	8.79e-05	0.000244	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—rheumatoid arthritis	8.78e-05	0.000244	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—rheumatoid arthritis	8.78e-05	0.000244	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.77e-05	0.000645	CbGpPWpGaD
Sitaxentan—Dermatitis—Methylprednisolone—rheumatoid arthritis	8.77e-05	0.000244	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—rheumatoid arthritis	8.76e-05	0.000244	CcSEcCtD
Sitaxentan—Headache—Triamcinolone—rheumatoid arthritis	8.74e-05	0.000243	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—rheumatoid arthritis	8.74e-05	0.000643	CbGpPWpGaD
Sitaxentan—Headache—Methylprednisolone—rheumatoid arthritis	8.72e-05	0.000242	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.72e-05	0.000641	CbGpPWpGaD
Sitaxentan—Body temperature increased—Prednisone—rheumatoid arthritis	8.71e-05	0.000242	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CSF2—rheumatoid arthritis	8.67e-05	0.000638	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—POMC—rheumatoid arthritis	8.66e-05	0.000637	CbGpPWpGaD
Sitaxentan—Diarrhoea—Betamethasone—rheumatoid arthritis	8.66e-05	0.000241	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—rheumatoid arthritis	8.66e-05	0.000241	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2RA—rheumatoid arthritis	8.61e-05	0.000633	CbGpPWpGaD
Sitaxentan—Hypotension—Methotrexate—rheumatoid arthritis	8.61e-05	0.000239	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	8.6e-05	0.000633	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	8.6e-05	0.000633	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT1—rheumatoid arthritis	8.56e-05	0.00063	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCF2—rheumatoid arthritis	8.55e-05	0.000629	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—C3—rheumatoid arthritis	8.54e-05	0.000628	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL2—rheumatoid arthritis	8.48e-05	0.000624	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6R—rheumatoid arthritis	8.45e-05	0.000622	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL10—rheumatoid arthritis	8.44e-05	0.000621	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	8.44e-05	0.000621	CbGpPWpGaD
Sitaxentan—Dizziness—Betamethasone—rheumatoid arthritis	8.37e-05	0.000233	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—rheumatoid arthritis	8.37e-05	0.000233	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—SH2B3—rheumatoid arthritis	8.34e-05	0.000613	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TRAF6—rheumatoid arthritis	8.34e-05	0.000613	CbGpPWpGaD
Sitaxentan—Insomnia—Methotrexate—rheumatoid arthritis	8.33e-05	0.000232	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—rheumatoid arthritis	8.29e-05	0.00023	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—GZMB—rheumatoid arthritis	8.28e-05	0.000609	CbGpPWpGaD
Sitaxentan—Nausea—Methylprednisolone—rheumatoid arthritis	8.27e-05	0.00023	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—rheumatoid arthritis	8.19e-05	0.000228	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisone—rheumatoid arthritis	8.12e-05	0.000226	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—rheumatoid arthritis	8.11e-05	0.000226	CcSEcCtD
Sitaxentan—Vomiting—Betamethasone—rheumatoid arthritis	8.05e-05	0.000224	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—rheumatoid arthritis	8.05e-05	0.000224	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CXCL2—rheumatoid arthritis	8.04e-05	0.000592	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL3—rheumatoid arthritis	8.04e-05	0.000592	CbGpPWpGaD
Sitaxentan—Decreased appetite—Methotrexate—rheumatoid arthritis	8.01e-05	0.000223	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8e-05	0.000588	CbGpPWpGaD
Sitaxentan—Rash—Betamethasone—rheumatoid arthritis	7.98e-05	0.000222	CcSEcCtD
Sitaxentan—Rash—Dexamethasone—rheumatoid arthritis	7.98e-05	0.000222	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—rheumatoid arthritis	7.97e-05	0.000222	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—rheumatoid arthritis	7.97e-05	0.000222	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.95e-05	0.000221	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—rheumatoid arthritis	7.94e-05	0.000221	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—rheumatoid arthritis	7.93e-05	0.000584	CbGpPWpGaD
Sitaxentan—Headache—Betamethasone—rheumatoid arthritis	7.93e-05	0.000221	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—rheumatoid arthritis	7.93e-05	0.000221	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—rheumatoid arthritis	7.91e-05	0.00022	CcSEcCtD
Sitaxentan—Pain—Methotrexate—rheumatoid arthritis	7.88e-05	0.000219	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—SAA1—rheumatoid arthritis	7.86e-05	0.000579	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2RA—rheumatoid arthritis	7.82e-05	0.000575	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—C3—rheumatoid arthritis	7.75e-05	0.00057	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP3—rheumatoid arthritis	7.7e-05	0.000567	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCF1—rheumatoid arthritis	7.7e-05	0.000567	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—TYK2—rheumatoid arthritis	7.7e-05	0.000566	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.69e-05	0.000566	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Methotrexate—rheumatoid arthritis	7.59e-05	0.000211	CcSEcCtD
Sitaxentan—Diarrhoea—Prednisone—rheumatoid arthritis	7.54e-05	0.00021	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—rheumatoid arthritis	7.52e-05	0.000209	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—rheumatoid arthritis	7.52e-05	0.000209	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PTK2—rheumatoid arthritis	7.41e-05	0.000545	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD28—rheumatoid arthritis	7.41e-05	0.000545	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7.38e-05	0.000543	CbGpPWpGaD
Sitaxentan—Urticaria—Methotrexate—rheumatoid arthritis	7.32e-05	0.000204	CcSEcCtD
Sitaxentan—Dizziness—Prednisone—rheumatoid arthritis	7.29e-05	0.000203	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—rheumatoid arthritis	7.28e-05	0.000203	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCL5—rheumatoid arthritis	7.27e-05	0.000535	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CSF2—rheumatoid arthritis	7.16e-05	0.000527	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FADS2—rheumatoid arthritis	7.13e-05	0.000525	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—rheumatoid arthritis	7.05e-05	0.000519	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.01e-05	0.000516	CbGpPWpGaD
Sitaxentan—Vomiting—Prednisone—rheumatoid arthritis	7.01e-05	0.000195	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.97e-05	0.000513	CbGpPWpGaD
Sitaxentan—Rash—Prednisone—rheumatoid arthritis	6.95e-05	0.000193	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—rheumatoid arthritis	6.94e-05	0.000193	CcSEcCtD
Sitaxentan—Headache—Prednisone—rheumatoid arthritis	6.91e-05	0.000192	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	6.84e-05	0.000503	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL12—rheumatoid arthritis	6.84e-05	0.000503	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.84e-05	0.000503	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—POMC—rheumatoid arthritis	6.83e-05	0.000502	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.79e-05	0.000189	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.78e-05	0.000499	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.76e-05	0.000497	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SPP1—rheumatoid arthritis	6.73e-05	0.000495	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.7e-05	0.000493	CbGpPWpGaD
Sitaxentan—Asthenia—Methotrexate—rheumatoid arthritis	6.61e-05	0.000184	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—rheumatoid arthritis	6.55e-05	0.000482	CbGpPWpGaD
Sitaxentan—Nausea—Prednisone—rheumatoid arthritis	6.55e-05	0.000182	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	6.5e-05	0.000478	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2RA—rheumatoid arthritis	6.45e-05	0.000475	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—rheumatoid arthritis	6.4e-05	0.000471	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—C3—rheumatoid arthritis	6.4e-05	0.000471	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.38e-05	0.000469	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SYK—rheumatoid arthritis	6.36e-05	0.000468	CbGpPWpGaD
Sitaxentan—Diarrhoea—Methotrexate—rheumatoid arthritis	6.3e-05	0.000175	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.24e-05	0.000459	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—rheumatoid arthritis	6.2e-05	0.000456	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT1—rheumatoid arthritis	6.13e-05	0.000451	CbGpPWpGaD
Sitaxentan—Dizziness—Methotrexate—rheumatoid arthritis	6.09e-05	0.000169	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—rheumatoid arthritis	6.07e-05	0.000446	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6R—rheumatoid arthritis	6.05e-05	0.000445	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—POMC—rheumatoid arthritis	6.04e-05	0.000445	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL10—rheumatoid arthritis	6.04e-05	0.000445	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—LEP—rheumatoid arthritis	5.96e-05	0.000438	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.93e-05	0.000436	CbGpPWpGaD
Sitaxentan—Vomiting—Methotrexate—rheumatoid arthritis	5.86e-05	0.000163	CcSEcCtD
Sitaxentan—Rash—Methotrexate—rheumatoid arthritis	5.81e-05	0.000162	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—rheumatoid arthritis	5.8e-05	0.000161	CcSEcCtD
Sitaxentan—Headache—Methotrexate—rheumatoid arthritis	5.77e-05	0.00016	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—FN1—rheumatoid arthritis	5.62e-05	0.000413	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6ST—rheumatoid arthritis	5.6e-05	0.000412	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP3—rheumatoid arthritis	5.51e-05	0.000405	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	5.51e-05	0.000405	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—TYK2—rheumatoid arthritis	5.51e-05	0.000405	CbGpPWpGaD
Sitaxentan—Nausea—Methotrexate—rheumatoid arthritis	5.47e-05	0.000152	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.4e-05	0.000397	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—rheumatoid arthritis	5.39e-05	0.000396	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTK2—rheumatoid arthritis	5.31e-05	0.00039	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.28e-05	0.000389	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL5—rheumatoid arthritis	5.2e-05	0.000383	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CSF2—rheumatoid arthritis	5.12e-05	0.000377	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—POMC—rheumatoid arthritis	5.12e-05	0.000376	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—rheumatoid arthritis	5.05e-05	0.000371	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—rheumatoid arthritis	5.01e-05	0.000368	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6R—rheumatoid arthritis	4.99e-05	0.000367	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SPP1—rheumatoid arthritis	4.82e-05	0.000354	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.8e-05	0.000353	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLD4—rheumatoid arthritis	4.76e-05	0.00035	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—rheumatoid arthritis	4.69e-05	0.000345	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RA—rheumatoid arthritis	4.62e-05	0.00034	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	4.59e-05	0.000338	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—rheumatoid arthritis	4.58e-05	0.000337	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—C3—rheumatoid arthritis	4.58e-05	0.000337	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TYK2—rheumatoid arthritis	4.55e-05	0.000334	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—rheumatoid arthritis	4.46e-05	0.000328	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	4.34e-05	0.000319	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	4.32e-05	0.000318	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	4.29e-05	0.000315	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LEP—rheumatoid arthritis	4.26e-05	0.000314	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GC—rheumatoid arthritis	4.2e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	4.2e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	4.19e-05	0.000308	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FN1—rheumatoid arthritis	4.02e-05	0.000296	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6ST—rheumatoid arthritis	4e-05	0.000295	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—rheumatoid arthritis	3.96e-05	0.000291	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	3.94e-05	0.00029	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	3.91e-05	0.000287	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—rheumatoid arthritis	3.85e-05	0.000284	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GC—rheumatoid arthritis	3.83e-05	0.000282	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	3.83e-05	0.000282	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—rheumatoid arthritis	3.78e-05	0.000278	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—rheumatoid arthritis	3.76e-05	0.000277	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—rheumatoid arthritis	3.66e-05	0.000269	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	3.63e-05	0.000267	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—rheumatoid arthritis	3.58e-05	0.000264	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—rheumatoid arthritis	3.58e-05	0.000263	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6R—rheumatoid arthritis	3.57e-05	0.000263	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	3.56e-05	0.000262	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NFKB1—rheumatoid arthritis	3.54e-05	0.000261	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK8—rheumatoid arthritis	3.48e-05	0.000256	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MED1—rheumatoid arthritis	3.43e-05	0.000252	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TYK2—rheumatoid arthritis	3.25e-05	0.000239	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—rheumatoid arthritis	3.22e-05	0.000237	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—rheumatoid arthritis	3.19e-05	0.000235	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	3.18e-05	0.000234	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	3.18e-05	0.000234	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MED1—rheumatoid arthritis	3.12e-05	0.00023	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—rheumatoid arthritis	2.95e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	2.9e-05	0.000214	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	2.9e-05	0.000214	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BGN—rheumatoid arthritis	2.87e-05	0.000211	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	2.86e-05	0.00021	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—rheumatoid arthritis	2.83e-05	0.000208	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	2.76e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—rheumatoid arthritis	2.71e-05	0.000199	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—rheumatoid arthritis	2.69e-05	0.000198	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	2.64e-05	0.000194	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BGN—rheumatoid arthritis	2.61e-05	0.000192	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	2.6e-05	0.000191	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—rheumatoid arthritis	2.56e-05	0.000189	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—rheumatoid arthritis	2.54e-05	0.000187	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.53e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.53e-05	0.000186	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK8—rheumatoid arthritis	2.49e-05	0.000183	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—rheumatoid arthritis	2.43e-05	0.000179	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	2.41e-05	0.000177	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.35e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.32e-05	0.000171	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—rheumatoid arthritis	2.3e-05	0.000169	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—rheumatoid arthritis	2.22e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.15e-05	0.000158	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.12e-05	0.000156	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.12e-05	0.000156	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—rheumatoid arthritis	2.11e-05	0.000155	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.06e-05	0.000152	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	1.96e-05	0.000144	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.93e-05	0.000142	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.92e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.92e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.85e-05	0.000136	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—rheumatoid arthritis	1.74e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.72e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.69e-05	0.000124	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—rheumatoid arthritis	1.59e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.59e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.55e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.41e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.29e-05	9.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.29e-05	9.51e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.18e-05	8.67e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.03e-05	7.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—rheumatoid arthritis	9.42e-06	6.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—rheumatoid arthritis	9.42e-06	6.93e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—rheumatoid arthritis	9.31e-06	6.85e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	9.01e-06	6.63e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—rheumatoid arthritis	8.59e-06	6.32e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	8.24e-06	6.06e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	8.22e-06	6.05e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	7.77e-06	5.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	7.52e-06	5.53e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—rheumatoid arthritis	6.22e-06	4.57e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—rheumatoid arthritis	5.67e-06	4.17e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	5.42e-06	3.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	4.96e-06	3.65e-05	CbGpPWpGaD
